Emerging and re-emerging infections: threat to the world

Harish Veerapalli


Emerging and reemerging infections are a huge threat to the human race which can destabilize humans from the roots. It is a global problem and not a problem for any single country. 15 million deaths occur annually across the globe due to infections, and 12% of them are due to emerging pathogens. These infections are returning every year with an increased incidence rate and higher virulence. In the present era of globalization and living conditions, such as living in crowded areas increases the potential for the spread of these emerging and reemerging infections, eventually affecting public health. The most prominent challenge that poses in the face of public health officials is the achievement of global preparedness to combat these infections. Aggressive research is needed in this field to help being prepared for an attack by these infections. Global organizational cooperation, international research funding, and poverty reduction are very much necessary for taking measures against these infections.


Emerging infections, Public health, Research, Re-emerging infections

Full Text:



Nii-Trebi NI. Emerging and Neglected Infectious Diseases: Insights, Advances, and Challenges. BioMed Res Inter. 2017;2017:15.

Beigi RH. Emerging infectious diseases in pregnancy. Obstet Gynecol. 2017;129(5):896-906.

Dye C. After 2015: infectious diseases in a new era of health and development. Philos Trans R Soc Lond B Biol Sci. 2014;369(1645):20130426.

Morens DM, Fauci AS. Emerging infectious diseases: threats to human health and global stability. PLOS Pathogens. 2013;9(7):e1003467.

Bhatia R. Emerging challenges and opportunities in medical microbiology. Indian J Med Microbiol. 2017;35(1):4-7.

van Doorn HR. Emerging infectious diseases. Medicine (Abingdon). 2014;42(1):60-3.

Walker NF, Whitty CJ. Tackling emerging infections: clinical and public health lessons from the West African Ebola virus disease outbreak, 2014-2015. Clin Med (Lond). 2015;15(5):457-60.

Holmberg M. Public health and infections: Health in Sweden: The National Public Health Report 2012. Chapter 15. Scandinavian J Pub Health. 2012;40(9suppl):275-80.

Rahim MA, Uddin KN. Chikungunya: an emerging viral infection with varied clinical presentations in Bangladesh: Reports of seven cases. BMC Res Notes. 2017;10(1):410-0.

Alhazmi MI. Isolation of Aeromonas spp. from Food Products: Emerging Aeromonas Infections and Their Significance in Public Health. J AOAC Int. 2015(4):927.

McFee RB. Selected epidemics and emerging pathogens. Disease-a-Month. 2017;63(9):240-6.

Nguyen-Van-Tam JS, Sellwood C. Intervention strategies for emerging respiratory virus infections: policy and public health considerations. Current Opin Virol. 2013;3(2):192-8.

Lynfield R, Schaffner W. Emerging Infections Program--20 Years of Achievements and Future Prospects. Emerg Infect Dis. 2015;21(9):1497-8.

Centers for Disease Control and Prevention (CDC). Emerging infections programs. 2017. Available at: Accessed on 8th June 2017.

Chan JFW, Sridhar S, Yip CCY, Lau SKP, Woo PCY. The role of laboratory diagnostics in emerging viral infections: the example of the Middle East respiratory syndrome epidemic. J Microbiol. 2017;55(3):172-82.

Everts M, Cihlar T, Bostwick JR, Whitley RJ. Accelerating drug development: antiviral therapies for emerging viruses as a model. Ann Review Pharmacol Toxicol. 2017;57(1):155-69.

Morrison C. DNA vaccines against Zika virus speed into clinical trials. Nature Reviews Drug Discover. 2016;15(8):521-2.

Jeong H, Seong BL. Exploiting virus-like particles as innovative vaccines against emerging viral infections. J Microbiol. 2017;55(3):220-30.

Lev O, Rager-Zisman B. Protecting public health in the age of emerging infections. IMAJ -RAMAT GAN. 2014;16(11):677-82.

Hadler JL, Vugia, D, Bennett NM, Moore MR. Emerging infections program efforts to address health equity. Emerg Infect Dis. 2015;21(9):1589-94.

Bell BP, Boyle CA, Petersen LR. Preventing zika virus infections in pregnant women: an urgent public health priority. Am J Public Health. 2016;106(4):589-90.

Rönn M, Hughes G, Simms I. Challenges presented by re-emerging sexually transmitted infections: an observational study of lymphogranuloma venereum in the UK. The Lancet. 2013:382-S86.

Banerjee A. Zika virus: another call for paradigm shift in disease control strategy. Med J Dr DY Patil University. 2016;9:288.